Cargando…

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni

Monitoring and evaluation (M&E) programmes are used to collect data which are required to assess the impact of current interventions on their progress towards achieving the World Health Organization (WHO) goals of morbidity control and elimination as a public health problem for schistosomiasis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Toor, Jaspreet, Turner, Hugo C., Truscott, James E., Werkman, Marleen, Phillips, Anna E., Alsallaq, Ramzi, Medley, Graham F., King, Charles H., Anderson, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175503/ https://www.ncbi.nlm.nih.gov/pubmed/30296257 http://dx.doi.org/10.1371/journal.pntd.0006717

Ejemplares similares

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
por: Toor, Jaspreet, et al.
Publicado: (2019)

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
por: Toor, Jaspreet, et al.
Publicado: (2018)

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020)

Application of Schistosomiasis Consortium for Operational Research and Evaluation Study Findings to Refine Predictive Modeling of Schistosoma mansoni and Schistosoma haematobium Control in Sub-Saharan Africa
por: King, Charles H., et al.
Publicado: (2020)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019)

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
por: Werkman, Marleen, et al.
Publicado: (2017)

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
por: Truscott, J.E., et al.
Publicado: (2017)

SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
por: Graham, Matthew, et al.
Publicado: (2021)

Schistosomiasis (Schistosoma mansoni)—a rare cause of complex liver cysts
por: Chmielewski, Jan, et al.
Publicado: (2023)

Atypical presentation of cerebral schistosomiasis four years after exposure to Schistosoma mansoni()
por: Rose, Matthew F., et al.
Publicado: (2014)

Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis
por: Hai, Yang, et al.
Publicado: (2014)

Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines
por: Alsallaq, Ramzi A., et al.
Publicado: (2017)

T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine
por: López-Abán, Julio, et al.
Publicado: (2021)

Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections
por: Farrell, Sam H, et al.
Publicado: (2018)

Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
por: Turner, Hugo C., et al.
Publicado: (2020)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

A Bayesian approach to estimate the age-specific prevalence of Schistosoma mansoni and implications for schistosomiasis control
por: Raso, Giovanna, et al.
Publicado: (2007)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
por: Geyer, Kathrin K., et al.
Publicado: (2011)

Genital Schistosomiasis: A Report on Two Cases of Ovarian Carcinomas Containing Viable Eggs of Schistosoma mansoni
por: Gonçalves Amorim, Andressa, et al.
Publicado: (2014)

Vaccination with Schistosoma mansoni Cholinesterases Reduces the Parasite Burden and Egg Viability in a Mouse Model of Schistosomiasis
por: Tedla, Bemnet A., et al.
Publicado: (2020)

Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis
por: Mossallam, Shereen F., et al.
Publicado: (2021)

Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice
por: Hassan, Adam S., et al.
Publicado: (2023)

HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis
por: de Lima Fragelli, Bruna Dias, et al.
Publicado: (2023)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)

Schistosoma mansoni Vector Snails in Antigua and Montserrat, with Snail-Related Considerations Pertinent to a Declaration of Elimination of Human Schistosomiasis
por: Laidemitt, Martina R., et al.
Publicado: (2020)

The cercarial glycocalyx of Schistosoma mansoni
Publicado: (1985)

CARBOHYDRATE METABOLISM OF SCHISTOSOMA MANSONI
por: Bueding, Ernest
Publicado: (1950)

Imatinib activity on Schistosoma mansoni
por: Katz, Naftale, et al.
Publicado: (2013)

Chlorination of Schistosoma mansoni cercariae
por: Braun, Laura, et al.
Publicado: (2020)

Schistosoma mansoni FES Tyrosine Kinase Involvement in the Mammalian Schistosomiasis Outcome and Miracidia Infection Capability in Biomphalaria glabrata
por: Tavares, Naiara Clemente, et al.
Publicado: (2020)

Sulfonamide Inhibition Studies of an α-Carbonic Anhydrase from Schistosoma mansoni, a Platyhelminth Parasite Responsible for Schistosomiasis
por: Angeli, Andrea, et al.
Publicado: (2020)

Persistent Vulvar Itch Unresponsive to Treatment: A Case of Vulvar Schistosomiasis Caused by Schistosoma mansoni and a Brief Review of Literature
por: Gyening-Yeboah, Anthony, et al.
Publicado: (2023)

La Schistosomiasis Mansoni en Venezuela
por: Tager, M.
Publicado: (1943)

Pseudotumoral form of cerebral Schistosomiasis Mansoni
por: Romero, FR, et al.
Publicado: (2012)

Decline in transmission of schistosomiasis mansoni in Oman
por: Al Abaidani, Idris, et al.
Publicado: (2016)

Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis
por: Dias, Sílvia R. C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h8e4asnvr0h96c9qv9vcslbrfe